PCMC
IRWD icon

Planning Capital Management Corporation’s Ironwood Pharmaceuticals IRWD Stock Holding History

Planning Capital Management Corporation’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.37K Hold
1,303
– – ﹤0.01% 504
2024
Q2 		$8.5K Hold
1,303
– – 0.01% 423
2024
Q1 		$11.3K Buy
1,303
+1,050
+415% +$12.7K 0.01% 402
2023
Q4 		$2.9K Buy
+253
New +$2.5K ﹤0.01% 535

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Planning Capital Management Corporation's IRWD Position: Q3 2024 in Review

Planning Capital Management Corporation held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2024 at 1,303 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Planning Capital Management Corporation first reported a position in IRWD in Q4 2023 and has held it in 4 quarters since. The position peaked at $11.3K in Q1 2024. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Planning Capital Management Corporation held 1,303 shares of Ironwood Pharmaceuticals worth $5.37K as of Q3 2024.
  • Planning Capital Management Corporation left its Ironwood Pharmaceuticals share count unchanged in Q3 2024.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #504 holding.
  • Planning Capital Management Corporation first reported a position in Ironwood Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Planning Capital Management Corporation's Ironwood Pharmaceuticals position peaked at $11.3K in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.